Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000413735 | SCV000491026 | likely pathogenic | not provided | 2016-08-09 | criteria provided, single submitter | clinical testing | The E398X likely pathogenic variant in the MEGF10 gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. The E398X variant was not observed in approximately 6500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Therefore, we interpret the E398X variant as a likely pathogenic variant, |
Labcorp Genetics |
RCV003105889 | SCV003782061 | pathogenic | MEGF10-related myopathy | 2022-06-14 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with MEGF10-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Glu398*) in the MEGF10 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MEGF10 are known to be pathogenic (PMID: 22101682, 22371254, 23453856, 23954233). ClinVar contains an entry for this variant (Variation ID: 372648). For these reasons, this variant has been classified as Pathogenic. |